Vancomycin 750mg/150ml Inj, 150ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication safely and effectively, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the instructions closely. This medication is typically administered as an intravenous infusion, which means it is given into a vein over a period of time. In some cases, your doctor may prescribe an oral form of this medication, which can be taken by mouth or administered through a feeding tube as an alternative to an injection.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the best way to store it.
What to Do If You Miss a Dose
If you miss a dose, contact your doctor immediately to find out what steps to take next.
Lifestyle & Tips
- Report any changes in hearing or ringing in the ears immediately.
- Report any decrease in urine output or swelling.
- Inform healthcare providers about all medications, supplements, and herbal products being taken.
- Stay well-hydrated during treatment unless otherwise advised by your doctor.
Available Forms & Alternatives
Available Strengths:
- Vancomycin 1000mg Inj
- Vancomycin 500mg Vial Forinjection
- Vancomycin 500mg Inj, 1 Vial
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 1000mg Inj (ad-Vantage)
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 750mg Inj, 1 Vial
- Vancomycin 1gm Inj, 1 Vial
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin 1gm/200m Inj 12x200ml
- Vancomycin 250mg/5ml Oral Solution
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 1.25gm Inj 1 Vial
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 50mg/ml Oral Solution
- Vancomycin 1.5mg Inj, 1 Vial
- Vancomycin 1.75gm/350ml Inj, 350ml
- Vancomycin 750mg/150ml Inj, 150ml
- Vancomycin 1.5gm/300ml Inj, 300ml
- Vancomycin 500mg/100ml Inj, 100ml
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin Hcl 1.75gm Inj, 1 Vial
- Vancomycin Hcl 2gm Sdv Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, including:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, such as:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
If you receive this medication through a vein (intravenous injection):
+ Fever
+ Chills
+ Sore throat
+ Pain when passing urine
+ Changes in balance
+ Flushing
+ Rash on the face, neck, trunk, and arms during infusion
If the medication is given too quickly, you may experience:
+ Shortness of breath or wheezing
+ Itching
+ Muscle pain
+ Chest pain
+ Signs of low blood pressure, such as dizziness or fainting
If the medication leaks from the vein, it can cause tissue damage. Inform your nurse immediately if you experience:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid at the injection site
Other Possible Side Effects
Like all medications, this drug can cause side effects, although not everyone will experience them. If you have any of the following side effects or any other concerns, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe rash or hives
- Swelling of the face, lips, tongue, or throat
- Difficulty breathing or swallowing
- Dizziness or lightheadedness
- Sudden flushing, itching, or rash (Red Man Syndrome)
- Ringing in the ears (tinnitus)
- Hearing loss
- Decreased urination
- Unusual tiredness or weakness
- Fever or chills (could indicate neutropenia or new infection)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions or exacerbate underlying health issues.
To ensure your safety, it is crucial to verify that this medication can be taken safely with all your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
If you have a history of kidney problems, such as kidney failure, notify your doctor, as this medication can cause kidney issues. Your doctor will likely recommend regular blood work and other laboratory tests to monitor your condition.
Long-term use of this medication may increase the risk of permanent hearing loss. Do not exceed the prescribed duration of treatment, and immediately report any changes in your hearing or hearing loss to your doctor. Your doctor may recommend regular hearing tests during treatment.
To minimize the risk of a second infection, do not use this medication for longer than prescribed.
Antibiotics, including this medication, can cause diarrhea, which is usually mild. However, in rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) can occur, potentially leading to life-threatening bowel problems. CDAD may develop during or several months after antibiotic treatment. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor promptly. Before treating diarrhea, consult your doctor for advice.
This medication is not approved for injection into the eye, as it can cause severe eye problems, including permanent vision loss.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor. For women of childbearing age, your doctor may require a pregnancy test before initiating treatment to confirm that you are not pregnant.
Overdose Information
Overdose Symptoms:
- Severe nephrotoxicity (kidney failure)
- Ototoxicity (hearing loss, tinnitus, vertigo)
- Hypotension
- Red Man Syndrome (severe form)
What to Do:
Call 1-800-222-1222 (Poison Control). Treatment is supportive. Hemodialysis is not effective for removing vancomycin due to its large molecular size and protein binding, but hemofiltration/hemoperfusion may be considered in severe cases. Maintain hydration and monitor renal function.
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin): Increased risk of nephrotoxicity and ototoxicity.
- Loop Diuretics (e.g., furosemide): May increase risk of ototoxicity.
- Cisplatin: Increased risk of nephrotoxicity and ototoxicity.
- Cyclosporine: Increased risk of nephrotoxicity.
- Tacrolimus: Increased risk of nephrotoxicity.
- Neuromuscular Blocking Agents (e.g., succinylcholine, rocuronium): Vancomycin may potentiate and prolong neuromuscular blockade.
Moderate Interactions
- Metformin: Vancomycin may increase metformin concentrations by inhibiting OCT1/2, potentially increasing risk of lactic acidosis (rare, but theoretical).
- Colistin: Increased risk of nephrotoxicity.
- Polymyxin B: Increased risk of nephrotoxicity.
- Amphotericin B: Increased risk of nephrotoxicity.
Monitoring
Baseline Monitoring
Rationale: Vancomycin is primarily renally eliminated; renal impairment necessitates dose adjustment and increases risk of nephrotoxicity.
Timing: Prior to initiation of therapy.
Rationale: Vancomycin can cause ototoxicity, especially at high concentrations or with concomitant ototoxic drugs.
Timing: Prior to initiation, particularly in high-risk patients.
Rationale: To establish baseline and monitor for potential neutropenia or thrombocytopenia (rare adverse effects).
Timing: Prior to initiation.
Routine Monitoring
Frequency: Prior to the 4th or 5th dose (at steady state) and then at least weekly for stable patients, or more frequently (e.g., every 2-3 days) in unstable patients, those with changing renal function, or those on continuous renal replacement therapy.
Target: 10-15 mcg/mL for most infections; 15-20 mcg/mL for severe infections (e.g., endocarditis, osteomyelitis, pneumonia, bacteremia, meningitis).
Action Threshold: Levels outside target range warrant dose or interval adjustment. Levels >20 mcg/mL increase risk of toxicity.
Frequency: At least 2-3 times per week, or daily in critically ill patients or those with unstable renal function.
Target: Stable baseline values.
Action Threshold: Increase in SCr by âĨ0.5 mg/dL or âĨ50% from baseline (whichever is greater) suggests acute kidney injury and requires dose adjustment or discontinuation.
Frequency: Daily in hospitalized patients.
Target: Adequate hydration and urine output.
Action Threshold: Oliguria or significant fluid retention may indicate renal impairment.
Symptom Monitoring
- Signs of nephrotoxicity (decreased urine output, swelling, fatigue)
- Signs of ototoxicity (tinnitus, hearing loss, vertigo)
- Signs of Red Man Syndrome (flushing, rash, pruritus, urticaria, hypotension, tachycardia during or shortly after infusion)
- Signs of hypersensitivity reactions (rash, fever, chills)
- Signs of neutropenia (fever, sore throat, signs of infection)
- Signs of thrombophlebitis (pain, redness, swelling at infusion site)
Special Patient Groups
Pregnancy
Vancomycin is classified as Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Vancomycin crosses the placenta. Cases of fetal ototoxicity and nephrotoxicity have been reported, but a causal relationship has not been established.
Trimester-Specific Risks:
Lactation
Vancomycin is excreted into breast milk in small amounts. The risk of adverse effects in a breastfed infant appears to be low, but theoretical concerns include disruption of infant gut flora, allergic sensitization, and direct effects. Monitor the infant for diarrhea, candidiasis (thrush, diaper rash), or rash. Use with caution, especially in preterm or neonates.
Pediatric Use
Dosing is weight-based and adjusted for age and renal function. Neonates and infants have immature renal function, requiring careful monitoring and individualized dosing. Trough level monitoring is crucial to ensure efficacy and minimize toxicity. Higher clearance rates may be observed in older children compared to adults, potentially requiring more frequent dosing.
Geriatric Use
Elderly patients are more likely to have age-related decreases in renal function, which necessitates careful dose adjustment and more frequent monitoring of renal function and vancomycin trough levels. They may also be more susceptible to ototoxicity and nephrotoxicity. Initial doses should be conservative.
Clinical Information
Clinical Pearls
- Always administer vancomycin IV infusions slowly over at least 60 minutes (or 10 mg/min) to prevent Red Man Syndrome. For doses >1g, extend infusion time (e.g., 90-120 minutes for 1.5g, 120-180 minutes for 2g).
- Therapeutic drug monitoring (TDM) with trough levels is essential for optimizing efficacy and minimizing toxicity, especially for severe infections, unstable renal function, or prolonged therapy.
- Maintain adequate hydration to reduce the risk of nephrotoxicity.
- Avoid concomitant use with other nephrotoxic or ototoxic drugs whenever possible. If co-administration is necessary, monitor renal function and hearing even more closely.
- Vancomycin is NOT absorbed orally for systemic infections; oral vancomycin is used only for Clostridioides difficile infection.
- Consider continuous infusion vancomycin in critically ill patients or those with fluctuating renal function to maintain stable drug levels and potentially reduce toxicity.
Alternative Therapies
- Linezolid (for MRSA, VRE)
- Daptomycin (for MRSA, VRE)
- Ceftaroline (for MRSA)
- Tedizolid (for MRSA)
- Dalbavancin (for MRSA)
- Oritavancin (for MRSA)
- Quinupristin/Dalfopristin (for VRE, MRSA)